The News Of Tomorrow, Today
The News Of Tomorrow, Today
dementia
On Friday, the pharmaceutical company Biogen announced the Food and Drug Administration accepted its application to conduct a priority review of their experimental Alzheimer’s drug for approval. The speedier-than-usual process sets the stage for the treatment, called aducanumab, to be the first new approved drug for the incurable, degenerative condition…
New research is the latest to suggest that the condition of our mouth and teeth is intimately connected to our brain health. The study found an association between people having severe gum disease or missing teeth in their early 60’s and an increased risk of them developing cognitive problems and…
The field of Alzheimer’s research one filled with disappointment. Just last week, yet another drug failed its Phase 3 clinical trial, continuing the 15-year-long losing streak since a truly new Alzheimer’s treatment was approved by the Food and Drug Administration.
There are no more articles to be viewed
Haven't registered?
Sign up here
Lost your password?
Click here to reset
Back to Login?
Click here
Subscribe to our newsletter!
Now you can get the top stories from Gizmodo delivered to your inbox. Enter your email below.
By subscribing you agree to our Terms of Use and Privacy Policy.